Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 7,561 | 7,874 | 7,534 | 5,906 | 5,720 |
| Operating Income | -7,561 | -7,874 | -7,534 | -5,906 | -5,720 |
| Other Income | -74 | -4,971 | 23,086 | -19,493 | -12,089 |
| Pre-tax Income | -7,635 | -12,845 | 15,552 | -25,399 | -17,809 |
| Net Income Continuous | -7,635 | -12,845 | 15,552 | -25,399 | -17,809 |
| Net Income | $-7,635 | $-12,845 | $15,552 | $-25,399 | $-17,809 |
| EPS Basic Total Ops | -1.40 | -3.54 | 33.06 | -17.00 | -28.68 |
| EPS Basic Continuous Ops | -1.34 | -3.11 | 33.16 | -17.02 | -28.68 |
| EPS Diluted Total Ops | -1.40 | -3.54 | 33.06 | -17.00 | -28.68 |
| EPS Diluted Continuous Ops | -1.34 | -3.11 | 33.16 | -17.02 | -28.68 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.48 | N/A | -3.25 | -12.25 |
| EBITDA(a) | $-7,553 | $-7,866 | $-7,525 | $-5,884 | $-5,692 |